miR-133a-3p/FOXP3 axis regulates cell proliferation and autophagy in gastric cancer

Jia-Peng Li1, Hui-Min Zhang1, Mei-Jun Liu1

  • 1College of Life and Health Sciences, Institute of Biology and Medicine, Wuhan University of Science and Technology, Wuhan, Hubei, China.

Insights

MicroRNA miR-133a-3p and transcription factor FOXP3 influence gastric cancer (GC) cell proliferation and autophagy. Decreasing FOXP3 protein levels via miR-133a-3p boosts GC cell growth and autophagy, offering new therapeutic targets.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • Gastric cancer (GC) survival rates remain suboptimal despite advancements in treatment.
  • Understanding molecular mechanisms driving GC progression is crucial for developing effective therapies.

Purpose of the Study:

  • To investigate the roles of microRNA miR-133a-3p and transcription factor FOXP3 in gastric cancer cell proliferation and autophagy.
  • To elucidate the interaction between FOXP3, miR-133a-3p, and their impact on GC.

Main Methods:

  • Investigated the effects of FOXP3 knockdown on GC cell proliferation and autophagy.
  • Analyzed the direct binding of FOXP3 to the TP53 promoter region.
  • Examined the influence of miR-133a-3p on FOXP3 protein levels by targeting its 3'-UTR.

Main Results:

  • Knockdown of FOXP3 significantly increased proliferation and autophagy in GC cells.
  • FOXP3 was found to directly inhibit the expression of TP53.
  • miR-133a-3p was shown to upregulate GC cell proliferation and autophagy by reducing FOXP3 protein levels.

Conclusions:

  • FOXP3 plays an inhibitory role in gastric cancer cell proliferation and autophagy.
  • miR-133a-3p promotes GC progression by targeting FOXP3.
  • These findings offer novel insights into GC pathogenesis and potential therapeutic strategies.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.5K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.2K
Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
7.6K